يعرض 1 - 20 نتائج من 117 نتيجة بحث عن '"Alcantara-Neves, Neuza M."', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1
    Academic Journal

    وصف الملف: 32 Páginas; application/pdf

    Relation: Vargas, L., Prieto, L., Baquero, M., Corredor, W., Alcantara-Neves, N., Jaramillo-Hernández, D.(2022). Vaccines for gastrointestinal parasites, a pillar of preventive medicine in veterinary practice: Systematic review. Revista de Investigación Agraria y Ambiental, 13(1), 221 – 251. DOI: https://doi.org/10.22490/21456453.4544; Assana, E., Kyngdon, C. T., Gauci, C. G., Geerts, S., Dorny, P., De Deken, R., Anderson, G. A., Zoli, A. P. & Lightowlers, M. W. (2010). Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. International journal for Parasitology, 40(5), 515–519. https://doi.org/10.1016/j.ijpara.2010.01.006; Bartelt, L. A. & Platts-Mills, J. A. (2016). Giardia: a pathogen or commensal for children in high-prevalence settings? Current opinion in infectious diseases, 29(5), 502–507. https://doi.org/10.1097/QCO.0000000000000293; Blake, D. P., Pastor-Fernández, I., Nolan M. J. & Tomley, F. M. (2017). Recombinant anticoccidial vaccines - a cup half full? Infection, Genetics and Evolution, 55,358–365. https://doi.org/10.1016/j.meegid.2017.10.009.; Boag, P. R., Parsons, J. C., Presidente, P. J. A., Spithill, T. W. & Sexton, J. L. (2003). Characterisation of humoral immune responses in dogs vaccinated with irradiated Ancylostoma caninum. Veterinary immunology and immunopathology, 92(1- 2), 87–94. https://doi.org/10.1016/s0165- 2427(03)00006-0; Borloo, J., De Graef, J., Peelaers, I., Nguyen, D. L., Mitreva, M., Devreese, B., Hokke, C. H., Vercruysse, J., Claerebout, E. & Geldhof, P. (2013). In-depth proteomic and glycomic analysis of the adult-stage Cooperia oncophora excretome/secretome. Journal of proteome research, 12(9), 3900–3911. https://doi.org/10.1021/pr400114y; Britton, C., Emery, D. L., McNeilly, T. N., Nisbet, A. J. & Stear, M. J. (2020). The potential for vaccines against scour worms of small ruminants. International journal for Parasitology, 50(8), 533–553. https://doi.org/10.1016/j.ijpara.2020.04.003; Budke, C. M., Deplazes, P. & Torgerson, P. R. (2006). Global socioeconomic impact of cystic echinococcosis. Emerging infectious diseases, 12(2), 296–303. https://doi. org/10.3201/eid1202.050499; Cai, X., Yuan, G., Zheng, Y., Luo, X., Zhang, S., Ding, J., Jing, Z. & Lu, C. (2007). Effective production and purification of the glycosylated TSOL18 antigen, which is protective against pig cysticercosis. Infection and immunity, 76(2), 767–770. https://doi.org/10.1128/IAI.00444-07; Claerebout, E. & Geldhof, P. (2020). Helminth Vaccines in Ruminants: From Development to Application. Veterinary clinics of North America: Food animal practice, 36(1), 159–171. https://doi.org/10.1016/j.cvfa.2019.10.001; Corwin R. M. (1997). Economics of gastrointestinal parasitism of cattle. Veterinary parasitology, 72(3-4), 451–460. https://doi. org/10.1016/s0304-4017(97)00110-6; Dalimi, A., Motamedi, G., Hosseini, M.,Mohammadian, B., Malaki, H., Ghamari, Z. & Ghaffari-Far, F. (2002). Echinococcosis/ hydatidosis in western Iran. Veterinary parasitology, 105(2), 161–171. https://doi.org/10.1016/s0304-4017(02)00005-5; De Aluja, A. S., Villalobos, N. M., Nava, G., Toledo, A., Martínez, J. J., Plancarte, A., Rodarte, L. F., Fragoso, G. & Sciutto, E. (2005). Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs. Vaccine, 23(31), 4062–4069. https://doi.org/10.1016/j. vaccine.2004.11.076; Díaz, M. A., Villalobos, N., De Aluja, A., Rosas, G., Goméz-Conde, E., Hernández, P., Larralde, C., Sciutto, E., & Fragoso, G. (2003). Th1 and Th2 indices of the immune response in pigs vaccinated against Taenia solium cysticercosis suggest various host immune strategies against the parasite. Veterinary immunology and immunopathology, 93(34), 81–90. https://doi.org/10.1016/s01652427(03)00071-0; Ding, X., Lillehoj, H. S., Dalloul, R. A., Min, W., Sato, T., Yasuda, A. & Lillehoj, E. P. (2005). In ovo vaccination with the Eimeria tenella EtMIC2 gene induces protective immunity against coccidiosis. Vaccine, 23(28), 3733–3740. https://doi.org/10.1016/j. vaccine.2005.01.144; East, I. J., Berrie, D. A., & Fitzgerald, C. J. (1988). Oesophagostomum radiatum: successful vaccination of calves with an extract of in vitro cultured larvae. International journal for parasitology, 18(1), 125–127. https://doi.org/10.1016/00207519(88)90047-1; Ehsan M., Hu, R., Liang, Q., Hou, J., Song, X., Yan, R. Zhu, X. & Li, X. (2020). Advances in the development of antiHaemonchus contortus vaccines: Challenges, opportunities, and perspectives. Vaccines, 8(3), 555. https://doi.org/10.3390/ vaccines8030555; Emery, D. L., McClure, S. J., & Wagland, B. M. (1993). Production of vaccines against gastrointestinal nematodes of livestock. Immunology and cell biology, 71(5), 463–472. https://doi.org/10.1038/icb.1993.52; Fujiwara, R. T., Loukas, A., Mendez, S., Williamson, A. L., Bueno, L. L., Wang, Y., Samuel, A., Zhan, B., Bottazzi, M. E., Hotez, P. J. & Bethony, J. M. (2006). Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs. Vaccine, 24(4), 501–509. https://doi.org/10.1016/j.vaccine.2005.07.091; Fujiwara, R. T., Zhan, B., Mendez, S., Loukas, A., Bueno, L. L., Wang, Y., Plieskatt, J., Oksov, Y., Lustigman, S., Bottazzi, M. E., Hotez, P. & Bethony, J. M. (2007). Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. Clinical and vaccine immunology, 14(3), 281–287. DOI: https://doi.org/10.1128/CVI.00404-06; Garcia, H. H., González, A. E., Tsang, V. C. W., O'Neal, S. E., Llanos-Zavalaga, F., Gonzalvez, G., Romero, J., Rodriguez, S., Moyano, L. M., Ayvar, V., Diaz, A., Hightower, A., Craig, P. S., Lightowlers, M. W., Gauci, C. G., Leontsini, E., Gilman, R. H. Elimination of Taenia solium Transmission in Northern Peru. The New England journal of medicine, 374(24), 2335–2344. https://doi.org/10.1056/NEJMoa1515520; Gasbarre, L. C. & Douvres, F. W. (1987). Protection from parasite-induced weight loss by the vaccination of calves with excretory-secretory products of larval Oesophagostomum radiatum. Veterinary parasitology, 26(1-2), 95–105. https://doi.org/10.1016/0304-4017(87)90080-x; Gauci, C. G., Jayashi, C. M., González, A. E., Lackenby, J. & Lightowlers, M. W. (2012). Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens. Vaccine, 30(26), 3824–3828. https://doi.org/10.1016/j.vaccine.2012.04.019; Geldhof, P., Claerebout, E., Knox, D., Vercauteren, I., Looszova, A. & Vercruysse, J. (2002). Vaccination of calves against Ostertagia ostertagi with cysteine proteinase enriched protein fractions. Parasite immunology, 24(5), 263–270. https://doi.org/10.1046/j.1365-3024.2002.00461.x; Geldhof, P., Vercauteren, I., Vercruysse, J., Knox, D. P., Van Den Broeck, W. & Claerebout, E. (2004). Validation of the protective Ostertagia ostertagi ES-thiol antigens with different adjuvantia. Parasite immunology, 26(1), 37–43. https://doi.org/10.1111/j.0141-9838.2004.00681.x; Ghosh, K., Hawdon, J. & Hotez, P. (1996). Vaccination with alum-precipitated recombinant Ancylostoma-secreted protein 1 protects mice against challenge infections with infective hookworm (Ancylostoma caninum) larvae. The Journal of infectious diseases, 174(6), 1380–1383. https://doi.org/10.1093/infdis/174.6.1380; Gilbert, W., Bellet, C., Blake, D. P., Tomley, F. M. & Rushton, J. (2020). Revisiting the Economic Impacts of Eimeria and Its Control in European Intensive Broiler Systems with a Recursive Modeling Approach. Frontiers in Veterinary Science, 7, 757. https://doi.org/10.3389/fvets.2020.558182; González, A. E., Gauci, C. G., Barber, D., Gilman, R. H., Tsang, V. C. W., Garcia, H. H., Verastegui, M. & Lightowlers, M. W. (2005). Vaccination of pigs to control human neurocysticercosis. The American journal of tropical medicine and hygiene, 72(6), 837–839. https://doi.org/10.4269/ajtmh.2005.72.837; González-Sánchez, M. E., Cuquerella, M. & Alunda, J. M. (2018). Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose. PloS one, 13(3), 1-12. https://doi.org/10.1371/journal.pone.0193118; Grosso, G., Gruttadauria, S., Biondi, A., Marventano, S. & Mistretta, A. (2012). Worldwide epidemiology of liver hydatidosis including the Mediterranean area. World journal of gastroenterology, 18(13), 1425–1437. https://doi.org/10.3748/wjg.v18. i13.1425; Heath, D. D., Robinson, C., Shakes, T., Huang, Y., Gulnur, T., Shi, B., Zhang, Z., Anderson, G. A., & Lightowlers, M. W. (2012). Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis). Vaccine, 30(20), 3076–3081. https://doi.org/10.1016/j.vaccine.2012.02.073; Hein, W. R. & Harrison, G. B. L. (2005). Vaccines against veterinary helminths. Veterinary parasitology, 132(34), 217–222. https://doi.org/10.1016/j.vetpar.2005.07.006; Heldens, J. G. M., Patel, J. R., Chanter, N., Thij, G. J. T., Gravendijck, M., Schijns, V. E. J. C., Langen, A. & Schetters, T. P. M. (2008). Veterinary vaccine development from an industrial perspective. Veterinary journal,178(1), 7–20. https://doi.org/10.1016/j. tvjl.2007.11.009; Herd, R. P., Chappel, R. J. & Biddell, D. (1975). Immunization of dogs against Echinococcus granulosus using worm secretory antigens. International journal for parasitology, 5(4), 395–399. https://doi.org/10.1016/0020-7519(75)90004-1; Hotez, P. J., Hawdon, J. M., Cappello, M., Jones, B. F., Ghosh, K., Volvovitz, F. & Xiao, S. (1996). Molecular approaches to vaccinating against hookworm disease. Pediatric research, 40(4), 515–521. https://doi.org/10.1203/00006450-19961000000001; Innes, E. A., Bartley, P. M., Rocchi, M., Benavidas-Silvan, J., Burrells, A., Hotchkiss, E., Chianini, F., Canton, G. & Katzer, F. (2011). Developing vaccines to control protozoan parasites in ruminants: Dead or alive? Veterinary parasitology, 180(12), 155–163. https://doi.org/10.1016/j.vetpar.2011.05.036; Jacob, S. S., Cherian, S., Sumithra, T. G., Raina, O. K. & Sankar, M. (2013). Edible vaccines against veterinary parasitic diseases—current status and future prospects. Vaccine, 31(15), 1879–1885. https://doi.org/10.1016/j.vaccine.2013.02.022; Jaramillo-Hernández, D. A., SalazarGarcés, L.F., Baquero-Parra,M.M.,DaSilva-Pinheiro,C.&Alcantara-NevesN.M. (2020). Toxocariasis and Toxocaravaccine:a review.Orinoquia 24(2), 79-95. https://doi.org/10.22579/20112629.631; Jenkins M. C. (1998). Progress on developing a recombinant coccidiosis vaccine. International journal for Parasitology, 28(7), 1111–1119. https://doi.org/10.1016/s00207519(98)00041-1; Jenkins, M. C. (2001). Advances and prospects for subunit vaccines against protozoa of veterinary importance. Veterinary Parasitology, 101(3-4),291-310. https://doi.org/10.1016/s0304-4017(01)00557-x.; Knox, D. P. (2000). Development of vaccines against gastrointestinal nematodes. Parasitology, 120(7), 43–61. https://doi.org/10.1017/s0031182099005764; Knox, D. P. & Smith, W. D. (2001). Vaccination against gastrointestinal nematode parasites of ruminants using gutexpressed antigens. Veterinary parasitology, 100(1-2), 21–32. https://doi.org/10.1016/s0304-4017(01)00480-0; Knox, D. P., Redmond, D. L., Newlands, G. F., Skuce, P. J., Pettit, D. & Smith, W. D. (2003). The nature and prospects for gut membrane proteins as vaccine candidates for Haemonchus contortus and other ruminant trichostrongyloids. International journal for Parasitology, 33(11), 1129–1137. https://doi.org/10.1016/s0020-7519(03)00167-x; Kyngdon, C. T., Gauci, C. G., Gonzalez, A. E., Flisser, A., Zoli, A., Read, A. J., MartínezOcaña, J., Strugnell, R. A. & Lightowlers, M. W. (2006). Antibody responses and epitope specificities to theTaeniasolium cysticercosis vaccines TSOL18 and TSOL45-1A. Parasite immunology, 28(5), 191–199. https://doi.org/10.1111/j.1365-3024.2006.00820.x; Larrieu, E., Mujica, G., Araya, D., Labanchi, J. L., Arezo, M., Herrero, E., Santillán, G., Vizcaychipi, K., Uchiumi, L., Salvitti, J. C., Grizmado, C., Calabro, A., Talmon, G., Sepulveda, L., Galvan, J. M., Cabrera, M., Seleiman, M., Crowley, P., Cespedes, G … Lightowlers, M. W. (2019). Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: 8 years of work. Acta tropica, 191, 1–7. https://doi.org/10.1016/j.actatropica.2018.12.025; Larrieu, E., Mujica, G., Gauci, C. G., Vizcaychipi, K., Seleiman, M., Herrero, E., Labanchi, J. L., Araya, D., Sepúlveda, L., Grizmado, C., Calabro, A., Talmon, G., Poggio, T. V., Crowley, P., Cespedes, G., Santillán, G., García Cachau, M., Lamberti, R., Gino, L … Lightowlers, M. W. (2015). Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro, Argentina: Second Study of Impact. PLOS: Neglected Tropical Diseases, 9(10), 1-10. DOI: https://doi.org/10.1371/journal.pntd.0004134; Li, J., Zheng, J., Gong, P. & Zhang, X. (2012). Efficacy of Eimeria tenella rhomboidlike protein as a subunit vaccine in protective immunity against homologous challenge. Parasitology research, 110(3), 1139–1145.https://doi.org/10.1007/s00436-011-2603-1; Lightowlers, M. W., Jensen, O., Fernández, E., Iriarte, J. A., Woollard, D. J., Gauci, C. G., Jenkins, D. J. & Heath, D. D. (1999). Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. International journal for Parasitology, 29(4), 531–534. https://doi.org/10.1016/s0020-7519(99)00003-x; Lightowlers, M. W., Lawrence, S. B., Gauci, C. G., Young, J., Ralston, M. J., Maas, D. & Heath, D. D. (1996). Vaccination against hydatidosis using a defined recombinant antigen. Parasite immunology, 18(9), 457–462. https://doi.org/10.1111/j.1365-3024.1996.tb01029.x; Lightowlers, M. W. & Donadeu, M. (2017). Designing a Minimal Intervention Strategy to Control Taenia solium. Trends in Parasitology, 33(6), 426-434. https://doi.org/10.1016/j. pt.2017.01.011; Loukas, A., Bethony, J. M., Williamson, A. L., Goud, G. N., Mendez, S., Zhan, B., Hawdon, J. M., Bottazzi, M. E., Brindley, P. J. & Hotez, P. J. (2004). Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms. The Journal of infectious diseases, 189(10), 1952–1961.https://doi.org/10.1086/386346; Masure, D., Vlaminck, J., Wang, T., Chiers, K., Van den Broeck, W., Vercruysse, J. & Geldhof, P. (2013). A role for eosinophils in the intestinal immunity against infective Ascaris suum larvae. PLOS: Neglected Tropical Diseases, 7(3), 1-7. https://doi.org/10.1371/journal.pntd.0002138; Matthews, J. B., Geldhof, P., Tzelos, T. & Claerebout, E. (2016). Progress in the development of subunit vaccines for gastrointestinal nematodes of ruminants. Parasite immunology, 38(12), 744–753. https://doi.org/10.1111/pim.12391; McDonald, V. & Shirley, M. W. (2009). Past and future: vaccination against Eimeria. Parasitology, 136(12), 1477–1489. https://doi.org/10.1017/S0031182009006349; Meeusen, E. N. T., Walker, J., Peters, A., Pastoret, P. & Jungersen, G. (2007). Current status of veterinary vaccines. Clinical microbiology reviews, 20(3), 489–510. https://doi.org/10.1128/CMR.00005-07; Merck Animal Health. (n.d). 0255 PB MAH-PPC Coccivac B52 2-20.indd (merckanimal-health-usa.com); Merck Animal Health. (n. d.). Intestinal health. https://www.merck-animal-health. com/species/poultry/intestinal-health/; Meyvis, Y., Geldhof, P., Gevaert, K., Timmerman, E., Vercruysse, J. & Claerebout, E. (2007). Vaccination against Ostertagia ostertagi with subfractions of the protective ES-thiol fraction. Veterinary parasitology, 149(3-4), 239–245. https://doi.org/10.1016/j.vetpar.2007.08.014; Miller, T. A. (1964). Effect of x-irradiation upon the infective larvae of ancylostoma caninum and the immunogenic effect in dogs of a single infection with 40 kr-irradiated larvae. The Journal of parasitology, 50(6), 735–742. https://doi.org/10.2307/3276194; Molina, V. M. (2017). Pharmacological treatment of giardiasis. In Rodriguez, A. J. (Ed.), Current Topics in Giardiasis (pp. 133– 145). IntechOpen. https://doi.org/10.5772/intechopen.71803; Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLOS medicine, 6(7), 1-6. https://doi.org/10.1371/journal.pmed.1000097; MSD Animal Health. (n.d.). Poultry. https://www.msd-animal-health-hub.co.uk/Products/Paracox; Munn, E. A., Greenwood, C. A., & Coadwell, W. J. (1987). Vaccination of young lambs by means of a protein fraction extracted from adult Haemonchus contortus. Parasitology, 94(2), 385–397. https://doi.org/10.1017/ s0031182000054032; Newton, S. E. & Meeusen, E. N. T. (2003). Progress and new technologies for developing vaccines against gastrointestinal nematode parasites of sheep. Parasite immunology, 25(5), 283–296. https://doi.org/10.1046/j.1365-3024.2003.00631.x; Newton, S. E. & Munn, E. A. (1999). The development of vaccines against gastrointestinal nematode parasites, particularly Haemonchus contortus. Parasitology today, 15(3), 116–122. https://doi.org/10.1016/s0169-4758(99)01399-x; Nisbet, A. J., McNeilly, T. N., Greer, A. W.,Bartley, Y., Oliver, E. M., Smith, S., PalareaAlbaladejo,J.&Matthews,J.B.(2016).Protection of ewes against Teladorsagia circumcincta infection in the periparturient period by vaccination with recombinant antigens. Veterinary parasitology, 228, 130–136. https://doi.org/10.1016/j.vetpar.2016.09.002; Nisbet, A. J., McNeilly, T. N., Wildblood, L. A., Morrison, A. A., Bartley, D. J., Bartley, Y., Longhi, C., McKendrick, I. J.,Palarea-Albaladejo, J. & Matthews, J. B. (2013). Successful immunization against a parasitic nematode by vaccination with recombinant proteins. Vaccine, 31(37), 4017–4023. https://doi.org/10.1016/j.vaccine.2013.05.026; Payne, P. A. & Artzer, M. (2009). The biology and control of Giardia spp and Tritrichomonas foetus. Veterinary clinics of North America: Small animal practice, 39(6), 993–1007. https://doi.org/10.1016/j.cvsm.2009.06.007; Peek, H. W. & Landman, W. J. M. (2011). Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Veterinary quarterly, 31(3), 143–161. https://doi.org/10.1080/01652176.2011.605247; Petavy, A. F., Hormaeche, C., Lahmar, S., Ouhelli, H., Chabalgoity, A., Marchal, T., Azzouz, S., Schreiber, F., Alvite, G., Sarciron, M. E., Maskell, D., Esteves, A. & Bosquet, G. (2008). An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study. PLOS: neglected tropical diseases, 2(1), 1-7. https://doi.org/10.1371/journal.pntd.0000125; against asites, Plancarte, A., Flisser, A., Gauci, C. G. & Lightowlers, M. W. (1999). Vaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigens. International journal for parasitology, 29(4), 643–647. https://doi.org/10.1016/s00207519(99)00021-1; Preston, S., Jabbar, A., Nowell, C., Joachim, A., Ruttkowski, B., Baell, J., Cardno, T., Korhonen, P. K., Piedrafita, D., Ansell, B. R. E., Jex, A. R., Hofmann, A. & Gasser, R. B. (2015). Low cost whole-organism screening of compounds for anthelmintic activity. International journal for parasitology, 45(5), 333–343. https://doi.org/10.1016/j.ijpara.2015.01.007; Redding, L. & Weiner, D. B. (2009). DNA vaccines in veterinary use. Expert review of vaccines, 8(9), 1251–1276. https://doi.org/10.1586/erv.09.77; Reid, W. M. (1990). History of avian medicine in the United States. X. Control of coccidiosis. Avian diseases, 34(3), 509–525.https://doi.org/10.2307/1591239; Sander, V. A., Sánchez López, E. F., Mendoza, L., Ramos, V. A., Corigliano, M. G. & Clemente, M. (2020). Use of Veterinary Vaccines for Livestock as a Strategy to Control Foodborne Parasitic Diseases. Frontiers in cellular and infection microbiology, 10 (288), 1-20. https://doi.org/10.3389/ fcimb.2020.00288; Schetters, T. (1995). Vaccine development from a commercial point of view. Veterinary parasitology, 57(1-3), 267–275. https://doi.org/10.1016/0304-4017(94)03125-g; Schetters, T. P. M. & Gravendyck, M. (2006). Regulations and procedures in parasite vaccine development. Parasitology, 133, 189–195. https://doi.org/10.1017/S0031182006001879; Sciutto, E., Fragoso, G., De Aluja, A. S., Hernández, M., Rosas, G. & Larralde, C. (2008). Vaccines against cysticercosis. Current topics in medicinal chemistry, 8(5), 415–423. https://doi.org/10.2174/156802608783790839; Sciutto, E., Fragoso, G., Hernández, M., Rosas, G., Martínez, J. J., Fleury, A., Cervantes, J., Aluja, A. & Larralde, C. (2013). Development of the S3Pvac vaccine against murine Taenia crassiceps cysticercosis: a historical review. The Journal of parasitology, 99(4), 693–702. https://doi.org/10.1645/GE-3101.1; Sepúlveda-Crespo, D., Reguera, R. M., Rojo-Vázquez, F., Balaña-Fouce, R., & Martínez-Valladares, M. (2020). Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics. Medicinal research reviews, 40(5), 1715–1753. https://doi.org/10.1002/med.21668; Sharma, N., Singh, V. & Shyma, K. P. (2015). Role of parasitic vaccines in integrated control of parasitic diseases in livestock. Veterinary world, 8(5), 590–598. https://doi.org/10.14202/vetworld.2015.590-598; Siefker, C. & Rickard, L. G. (2000). Vaccination of calves with Haemonchus placei intestinal homogenate. Veterinary parasitology, 88(3-4), 249–260. https://doi.org/10.1016/s0304-4017(99)00208-3; Smith, S. K. & Smith, W. D. (1996). Immunisation of sheep with an integral membrane glycoprotein complex of Haemonchus contortus and with its major polypeptide components. Research in veterinary science, 60(1), 1–6. https://doi.org/10.1016/s0034-5288(96)90121-6; Smith, S. K., Pettit, D., Newlands, G. F., Redmond, D. L., Skuce, P. J., Knox, D. P. & Smith, W. D. (1999). Further immunization and biochemical studies with a protective antigen complex from the microvillar membrane of the intestine of Haemonchus contortus. Parasite immunology, 21(4), 187–199. https://doi.org/10.1046/j.1365-3024.1999.00217.x; Smith, W. D. & Smith, S. K. (1993). Evaluation of aspects of the protection afforded to sheep immunised with a gut membrane protein of Haemonchus contortus. Research in veterinary science, 55(1), 1–9. https://doi.org/10.1016/0034-5288(93)90025-b; Smith, W. D., Smith, S. K. & Murray, J. M. (1994). Protection studies with integral membrane fractions of Haemonchus contortus. Parasite immunology, 16(5), 231–241. https://doi.org/10.1111/j.1365-3024.1994.tb00345.x; Smith, W. D., Smith, S. K., Pettit, D., Newlands, G. F. & Skuce, P. J. (2000). Relative protective properties of three membrane glycoprotein fractions from Haemonchus contortus. Parasite immunology, 22(2), 63–71. https://doi.org/10.1046/j.13653024.2000.00277.x; Song, H., Yan, R., Xu, L., Song, X., Shah, M. A., Zhu, H., & Li, X. (2010). Efficacy of DNA vaccines carrying Eimeria acervulina lactate dehydrogenase antigen gene against coccidiosis. Experimental parasitology, 126(2), 224–231. https://doi.org/10.1016/j.exppara.2010.05.015; Song, K. D., Lillehoj, H. S., Choi, K. D., Yun, C. H., Parcells, M. S., Huynh, J. T. & Han, J. Y. (2000). A DNA vaccine encoding a conserved Eimeria protein induces protective immunity against live Eimeria acervulina challenge. Vaccine, 19(2-3), 243–252. https://doi.org/10.1016/s0264-410x(00)00169-9; Song, X., Xu, L., Yan, R., Huang, X.Shah, M. A., & Li, X. (2009). The optimal immunization procedure of DNA vaccine pcDNA-TA4-IL-2 of Eimeria tenella and its cross-immunity to Eimeria necatrix and Eimeria acervulina. Veterinary parasitology, 159(1), 30–36. https://doi.org/10.1016/j.vetpar.2008.10.015; Soutter, F., Werling, D., Tomley, F. M. & Blake, D. P. (2020). Poultry Coccidiosis: Design and Interpretation of Vaccine Studies. Frontiers in veterinary science, 7, 101.: https://doi.org/10.3389/fvets.2020.00101; Stutzer, C., Richards, A., Ferreira, M., Baron, S. & Maritz-Olivier, C. (2018). Metazoan parasite vaccines: present status and future prospects. Frontiers in cellular and infection microbiology 8, 67. https://doi.org/10.3389/fcimb.2018.00067; Tecnovax. (n.d.) PROVIDEAN HIDATIL EG95. Retrieved from http://www.tecnovax.com.ar/productos/providean-hidatil-eg95/; Tsuji, N., Suzuki, K., Kasuga-Aoki, H., Isobe, T., Arakawa, T. & Matsumoto, Y. (2003). Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Infection and immunity, 71(9), 5314–5323.https://doi.org/10.1128/iai.71.9.53145323.2003; Unnikrishnan, M., Rappuoli, R. & Serruto, D. (2012). Recombinant bacterial vaccines. Current opinion in immunology, 24(3), 337–342. https://doi.org/10.1016/j.coi.2012.03.013; Urban, J. F.& Tromba, F. G. (1982). Development of immune responsiveness to Ascaris suum antigens in pigs vaccinated with ultraviolet-attenuated eggs. Veterinary immunology and immunopathology, 3(4), 399–409. https://doi.org/10.1016/01652427(82)90022-8; Verastegui, M., Gilman, R. H., Gonzales, A., Garcia, H. H., Gavidia, C., Falcon, N., Bernal, T., Arana, Y., Tsang, V. C. & Cysticercosis Working Group In Peru (2002). Taenia solium oncosphere antigens induce immunity in pigs against experimental cysticercosis. Veterinary parasitology, 108(1), 49–62. https://doi.org/10.1016/s0304-4017(02)00182-6; Vercauteren, I., Geldhof, P., Vercruysse, J., Peelaers, I., Van den Broeck, W., Gevaert, K., & Claerebout, E. (2004). Vaccination with an Ostertagia ostertagi polyprotein allergen protects calves against homologous challenge infection. Infection and immunity, 72(5), 2995–3001. https://doi.org/10.1128/iai.72.5.2995-3001.2004; Vercruysse, J., Charlier, J., Van Dijk, J., Morgan, E. R., Geary, T., Von Samson-Himmelstjerna, G. & Claerebout, E. (2018). Control of helminth ruminant infections by 2030. Parasitology, 145(13), 1655–1664. https://doi.org/10.1017/S003118201700227X; Vercruysse, J., Knox, D. P., Schetters, T. P. & Willadsen, P. (2004). Veterinary parasitic vaccines: pitfalls and future directions. Trends in parasitology, 20(10), 488–492. https://doi.org/10.1016/j.pt.2004.07.009; Vermeulen, A. N. (1998). Progress in recombinant vaccine development against coccidiosis. A review and prospects into the next millennium. International journal for parasitology, 28(7), 1121–1130. https://doi.org/10.1016/s0020-7519(98)00080-0; Versteeg, L., Almutairi, M. M., Hotez, P. J. & Pollet, J. (2019). Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections. Vaccines, 7(4), 122. https://doi.org/10.3390/vaccines7040122; Vlaminck, J., Borloo, J., Vercruysse, J., Geldhof, P. & Claerebout, E. (2015). Vaccination of calves against Cooperia oncophora with a double-domain activationassociated secreted protein reduces parasite egg output and pasture contamination. International journal for parasitology, 45(4), 209–213. https://doi.org/10.1016/j.ijpara.2014.11.001; Vlaminck, J., Martinez-Valladares, M., Dewilde, S., Moens, L., Tilleman, K., Deforce, D., Urban, J., Claerebout, E., Vercruysse, J. & Geldhof, P. (2011). Immunizing pigs with Ascaris suum haemoglobin increases the inflammatory response in the liver but fails to induce a protective immunity. Parasite immunology, 33(4), 250–254. https://doi.org/10.1111/j.1365-3024.2010.01274.x; Wallach, M., Smith, N. C., Petracca, M., Miller, C. M., Eckert, J. & Braun, R. (1995). Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine, 13(4), 347–354. https://doi.org/10.1016/0264410x(95)98255-9; Williams, R. B. (2002). Fifty years of anticoccidial vaccines for poultry (1952-2002). Avian diseases, 46(4), 775–802. https://doi.org/10.1637/0005-2086(2002)046[0775:FY OAVF]2.0.CO;2; Woods, D. J., Vaillancourt, V. A., Wendt, J. A. & Meeus, P. F. (2011). Discovery and development of veterinary antiparasitic drugs: past, present and future. Future medicinal chemistry, 3(7), 887–896. https://doi.org/10.4155/fmc.11.39; Xu, J., Zhang, Y. & Tao, J. (2013). Efficacy of a DNA vaccine carrying Eimeria maxima Gam56 antigen gene against coccidiosis in chickens. The Korean journal of parasitology, 51(2), 147–154. https://doi.org/10.3347/kjp.2013.51.2.147; Xu, Q., Song, X., Xu, L., Yan, R., Shah, M. A. A. & Li, X. (2008). Vaccination of chickens with a chimeric DNA vaccine encoding Eimeria tenella TA4 and chicken IL-2 induces protective immunity against coccidiosis. Veterinary parasitology, 156(3-4), 319–323. https://doi.org/10.1016/j.vetpar.2008.05.025; Zoetis (n.d.) Giardia Vax. https://ar.zoetis.com/products/caninos/giardia-vax.aspx; 251; Núm. 1; 221; Vol.13; Revista De Investigación Agraria Y Ambiental; Citación: Vargas, L., Prieto, L., Baquero, M., Corredor, W., Alcantara-Neves, N., Jaramillo-Hernández, D. (2022). Vaccines for gastrointestinal parasites, a pillar of preventive medicine in veterinary practice: Systematic review. Revista de Investigación Agraria y Ambiental, 13(1), 221 – 251. DOI: https://doi.org/10.22490/21456453.4544; https://repositorio.unillanos.edu.co/handle/001/3179; https://doi.org/10.22490/21456453.4544; Universidad de los Llanos; Repositorio Universidad de los Llanos; https://repositorio.unillanos.edu.co/

  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal

    وصف الملف: application/pdf

    Relation: Abo-Shehada MN, Al-Zubaidy BA, Herbert IV. Acquired immunity to Toxocara canis infection in mice. Vet. Parasitol. 1991;38:289-98.; Agudelo C, Villareal E, Cáceres E, López C, Eljach J, Ramírez N, Hernández C, Corredor A. Human and dogs Toxocara canis infection in a poor neighborhood in Bogotá. Mem. Inst. Oswaldo Cruz. 1990;85:75-78.; Alcântara-Neves NM, Bavia E, Silvão RM, Carvalho E. Environmental contamination by Toxocara sp eggs in public areas of Salvador, Bahia state, Brazil. Rev. Soc. Bras. Med. Trop. 1989;22:187-190.; Alcântara-Neves NM, dos Santos AB, Mendonça LR, Figueiredo CA, Pontes-de-Carvalho L. An improved method to obtain antigen-excreting Toxocara canis larvae. Exp. Parasitol. 2008;119:349-351.; Alcântara-Neves NM, de S G Britto G, Veiga RV, Figueiredo CA, Fiaccone RL, et al. Effects of helminth co-infections on atopy, asthma and cytokine production in children living in a poor urban area in Latin America. BMC Res. Notes. 2014;7:817.; Amerasinghe PH, Rajapakse RP, Lloyd T, Feernando ST. Antigen-induced protection against infection with Toxocara vitulorum larvae in mice. Parasitol. Res. 1992;78:643-647.; Amin MM, El-Kabany H. Evaluation of protective and treatment of Thyme (Thymus vulgaris) oil on Toxocara vitulorum infected rats. J. Rad. Res. Appl. Sci. 2013;1:209.; Aydenizöz-Ozkayhan M, YağcI BB, Erat S. The investigation of Toxocara canis eggs in coats of different dog breeds as a potential transmission route in human toxocariasis. Vet. Parasitol. 2008;152:94-100.; Barriga OO. A critical look at the importance, prevalence and control of toxocariasis and the possibilities of immunological control. Vet. Parasitol. 1988;29:195-234.; Barriga OO. Rational control of canine toxocariasis by the veterinary practioner. J. Am. Vet. Med. Assoc. 1991;98:216-221.; Batchelor DJ, Tzannes S, Graham PA, Wastling JM, Pinchbeck GL, German AJ. Detection of endoparasites with zoonotic potential in dogs with gastrointestinal disease in the UK. Transbound Emerg. Dis. 2008;55:99-104.; Beaver PC. Toxocariasis (visceral larva migrans) in relation to tropical eosinophilia. Bull. Soc. Path. Exot. 1962;55:555-576.; Berrett A. Toxocara Seroprevalence and Associated Risk Factors in the United States. Am. J. Trop. Med. Hyg. 2017;97:1846-1850.; Bonam SR, Partidos CD, Halmuthur SKM, Muller S. An overview of novel adjuvants designed for improving vaccine efficacy. Trends Pharmacol. Sci. 2017;38:771-793.; Bowman DD. Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States. Parasite. Vector. 2012;5:13.; Bowman DD. 2014. Helminths. Georgis’ Parasitology for Veterinarians E-Book, 10th ed. Saunders, St. Louis, MO, Pp. 122–240.; Buitrago B, Gast-Galvis A.Visceral larva migrans syndrome (Larval Granulomatosis) in Colombia. Rev. Soc. Colomb. Pediatr. Pueric. 1965;6:89-95.; CAPC, 2016. Companion Animal Parasite Council, Recommendations on Parasite Control—Hookworms. https://www.capcvet.org/capc-recommendations/hookworms/ (Search November 10, 2019); CDC, 2014. Centers for Disease Control and Prevention Neglected Parasitic Infections in the United States. http://www.cdc.gov/parasites/npi/index.html (Search October 02, 2017).; Chan YK, Gack MU. Viral evasion of intracellular DNA and RNA sensing. Nat. Rev. Microbiol. 2016;14:360-373.; Chen J, Liu Q, Liu GH, Zheng WB, Hong SJ, Sugiyama H, Zhu XQ, Elsheikha HM. Toxocariasis: a silent threat with a progressive public health impact. Infect. Dis. Poverty. 2018;7:59.; Cho HI, Celis E. Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects. Cancer Res. 2009;69:9012-9019.; Claerebout E. Giardia and other intestinal parasites in different dog populations in Northern Belgium. Vet. Parasitol. 2009;161:41-46.; Concepcion JE, Barriga OO. Transfer of infection-induced immune protection to Toxocara canis in a mouse model. Vet. Immunol. Immunopathol. 1985;9:371-382.; Cong W, Zhang XX, Zhou N, Yu CZ, Chen J, Wang XY, Li B, Quian AD, Zhu XQ. Toxocara seroprevalence among clinically healthy individuals, pregnant women and psychiatric patients and associated risk factors in Shandong Province, Eastern China. PLoS Negl. Trop. Dis. 2014;8:e3082.; Cooper PJ, Chico M, Sandoval C, Espinel I, Guevara A, Levine MM, Griffin GE, Nutman TB. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect. Immun. 2001;69:1574-1580.; da Silva MB, Urrego AJR, Oviedo Y, Cooper PJ, Pacheco LGC, Pinheiro CS, Ferreira F, Briza P, Alcantara-Neves NM. The somatic proteins of Toxocara canis larvae and excretory-secretory products revealed by proteomics. Vet. Parasitol. 2018;259:25-34.; Dai RS, Li ZY, Li F, Liu DX, Liu W, Liu GH, et al. Severe infection of adult dogs with helminths in Hunan Province, China poses significant public health concerns. Vet. Parasitol. 2009;160:348-350.; de Avila LFDC, Conceição FR, de Lima Telmo P, Dutra GF, de los Santos DG, Martins LHR, Berne NE, da Silva PE, Scaini CJ. Saccharomyces boulardii reduces infection intensity of mice with toxocariasis. Vet. Parasitol. 2012;187:337-340.; de Savigny DH, Voller A, Woodruff AW. Toxocariasis: serological diagnosis by enzyme-linked immunosorbent assay. J. Clin. Pathol. 1979;32:284-288.; Del Tordello E, Rappuoli R, Delany I. 2017. Reverse Vaccinology: Exploiting Genomes for Vaccine Design. In: Modjarrad, K., Koff, WC. (Eds). Human Vaccines Emerging Technologies in Design and Development. Ed. Academic Press. London, UK, Pp. 65-86.; Despommier D. Toxocariasis: Clinical Aspects, Epidemiology, Medical Ecology, and Molecular Aspects. Clin. Microbiol. Rev. 2003;16:265-272.; Didierlaurent AM, Laupèze B, Di Pasquale A, Hergli N, Collignon C, Garçon N. Adjuvant system AS01: helping to overcome the challenges of modern vaccines. Expert Rev. Vaccines. 2016;16:55-63.; Diemert DJ, Bottazzi ME, Plieskatt J, Hotez PJ, Bethony JM.Lessons along the critical path: developing vaccines against human helminths. Trends Parasitol. 2018;34:747-758.; Doğan EC, Dinleyici EÇ, Bor Ö, Töz SÖ, Özbel Y. Seroepidemiological survey for Toxocara canis infection in the northwestern part of Turkey. Turkiye Parazitol. Derg. 2007;31:288-291.; Du L, Wei H, Li L, Shan H, Yu Y, Wang Y, Zhang G. Regulation of recombinant Trichinella spiralis 53 kDa protein (rTsP53) on alternatively activated macrophages via STAT6 but not IL-4Rα in vitro. Cell. Immunol. 2014;288:1-7.; Dvorožňáková E. Immunomodulative effect of muramyldipeptide in mice with larval toxocarosis. Parasitol. Res. 1999;85:1034-1040.; Dvorožňáková E, Borošková Z, Dubinský P, Tomašovičová O, Machnicka B. Toxocara cants in mice: immune responses after infection and immunization. Helminthologia. 2000;37:199-204.; Dvorožňáková E, Borošková Z, Tomašovičová O. Immune responses in mice immunized with Toxocara canis antigens. Helminthologia. 2002;39:59-66.; Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008;453:1122-1126.; El-Kabany H. Biochemical and histopathological studies on liver of rats infected with non irradiated and/or Irradiated Toxocara vitulorum eggs. J. Radiat. Res. Appl. Sc. 2013;6:137-154.; Fallah A, Azimi A, Taherkhani H. Seroprevalence of toxocariasis in children aged 1–9 years in western Islamic Republic of Iran, 2003. East Mediterr. Health J. 2007;13:1073-1077.; Fisher M.Toxocara cati: an underestimated zoonotic agent. Trends Parasitol. 2003;19: 167-170.; Finsterer J, Auer H. Neurotoxocarosis. ver. Inst. Med. Trop. são. Paulo. 2007;49:279-287.; Fogt-Wyrwas R, Mizgajska-Wiktor H, Pacoń J, Jarosz W.Intraspecific variation between the ITS sequences of Toxocara canis, Toxocara cati and Toxascaris leonina from different host species in south-western Poland. J. Helminthol. 2013;87:432-442.; Gasser R, Zhu XQ, Jacobs DE, Hu M, Chilton NB. 2006. Molecular genetic characterization of members of the genus Toxocara - taxonomic, population genetic and epidemiological considerations. In: Holland, C.V., Smith, H.V. (1st ed). Toxocara The Enigmatic Parasite. CABI Publishing. United Kingdom, Wallingford, Pp. 18-31.; Gasser RB. A perfect time to harness advanced molecular technologies to explore the fundamental biology of Toxocara species. Vet. Parasitol. 2013;193:353-364.; Gauci Ch, Vural G, Öncel T, Varcasia A, Damian V, Kyngdon CT, Craig PS, Anderson GA, Lightowlers MW. Vaccination with recombinant oncosphere antigens reduces the susceptibility of sheep to infection with Taenia multiceps. Int J. Parasitol. 2008;38:1041-1050.; Gems DH, Ferguson CJ, Robertson BD, Nieves R, Page AP, Blaxter ML, Maizels RM. An abundant, trans-spliced mRNA from Toxocara canis infective larvae encodes a 26-kDa protein with homology to phosphatidylethanolamine-binding proteins. J. Biol. Chem. 1995;270:18517-18522.; Giraldo MI, García NL, Castaño JC. Prevalence of intestinal helminths in dogs from Quindio province. Biomédica. 2005;25:346-352.; González-Hernández A, Van Coppernolle S, Borloo J, Van Meulder F, Paerewijck O, Peelaers I, Leclercq G, Claerebout E, Geldhof P.Host protective ASP-based vaccine against the parasitic nematode Ostertagia ostertagi triggers NK cell activation and mixed IgG1-IgG2 response. Sci. Rep. 2016;6:29496.; Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111:927-930.; Grencis RK, Entwistle GM.Production of an interferon-gamma homologue by an intestinal nematode: functionally significant or interesting artefact? Parasitology. 1997;115:S101-106.; Habluetzel A, Traldi G, Ruggieri S, Attili AR, Scuppa P, Marchetti R, Menghini G, Esposito F. An estimation of Toxocara canis prevalence in dogs, environmental egg contamination and risk of human infection in the Marche region of Italy. Vet. Parasitol. 2003;113:243-252.; Hafez EN, Hafez MN, Amin MM. Effect of vaccination with irradiated Toxocara canis larvae or thyme oil treatment on testicular histochemical and immunohistochemical changes of rats. Trop. Biomed. 2019;36:430-442.; Han S. Clinical vaccine development. Clin. Exp. Vaccine. Res. 2015;4:46-53.; Haridy FM, Hassan AA, Hafez AO, El-Sherbini GT, Morsy TA. External and intestinal parasites of pet dogs with reference to zoonotic toxocariasis. J. Egypt. Soc. Parasitol. 2009;39:321-326.; Hayashi E. The high prevalence of asymptomatic Toxocara infection among schoolchildren in Manado, Indonesia, Southeast Asian. J. Trop. Med. Public Health. 2005;36:1399-1406.; Helmby H, Grencis RK. Essential role for TLR4 and MyD88 in the development of chronic intestinal nematode infection. Eur. J. Immunol. 2003;33:2974-2979.; Hewitson JP, Maizels RM. Vaccination against helminth parasite infections. Expert Rev. Vaccines. 2014;13:473-487.; Hewitson JP, Grainger JR, Maizels RM.Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol. Biochem. Parasitol. 2009;167:1-11.; HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine. 2002;20:S34-S39.; Holland CV. Knowledge gaps in the epidemiology of Toxocara: the enigma remains. Parasitology. 2017;144:81-94.; Hosin AB, Al- Kubaysi SMA. Efficiency of Immunization with the Hatching Fluid of Toxocara canis and Toxascaris leonina eggs against infection with Toxascaris leonina and Toxocara cati larvae. Al- Anbar J. Vet. Sci. 2008;1:1-9.; Hotez PJ, Wilkins PP. Toxocariasis: America’s most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl. Trop. Dis. 2009;3: e400.; Izzat NN, Olson JJ. Resistance of mice to Toxocara canis: effect of prechallenge infections and injection of worm extracts. Can. J. Zool. 1970;48:1063-1066.; Jacobs DE, Zhu X, Gasser RB, Chilton NB. PCR-based methods for identification of potentially zoonotic ascaridoid parasites of the dog, fox and cat. Acta Trop. 1997;68:191-200.; Jarosz W, Mizgajska-Wiktor H, Kirwan P, Konarski J, Rychlicki W, Wawrzyniak G. Developmental age, physical fitness and Toxocara seroprevalence amongst lower-secondary students living in rural areas contaminated with Toxocara eggs. Parasitology. 2010;137:53-63.; Jones L, Kruszon-Moran D, Won K, Wilson M, Schantz PM. Toxoplasma gondii and Toxocara spp. co-infection. Am. J. Trop. Med. Hyg. 2008;78:35-39.; Kennedy MW, Maizels RM, Meghji M, Young L, Qureshi F, Smith HV.Species-specific and common epitopes on the secreted and surface antigens of Toxocara cati and Toxocara canis infective larvae. Parasite Immunol. 1987;9:407-420.; Kamiya M, Ooi HK, Nomura T. The effect of radiation on the viability and migratory ability of second-stage larvae of Toxocara canis in mice. Vet. Parasitol. 1987;24:87-92. Kensil CR. Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carrier Syst. 1996;13:1-55.; Köhler P.The biochemical basis of anthelmintic action and resistance. Int. J. Parasitol. 2001;31:336-345.; Kollipara R, Peranteau AJ, Nawas ZY, Tong Y, Woc-Colburn L, Yan AC, Lupi O, Tyring SK. Emerging infectious diseases with cutaneous manifestations: fungal, helminthic, protozoan and ectoparasitic infections. J. Am. Acad. Dermatol. 2016;75:19-30.; Kopp SR, Coleman GT, Traub RJ, McCarthy JS, Kotze AC. Acetylcholine receptor subunit genes from Ancylostoma caninum: altered transcription patterns associated with pyrantel resistance. Int. J. Parasitol. 2009;39:435-441.; Layland LE, Straubinger K, Ritter M, Loffredo-Verde E, Garn H, Sparwasser T, da Costa CP. Schistosoma mansoni-mediated suppression of allergic airway inflammation requires patency and Foxp3+ Treg cells. PLoS Negl. Trop. Dis. 2013;7:e2379.; Le TH, Anh NTL, Nguyen KT, Nguyen NTB, Gasser RB. Toxocara malaysiensis infection in domestic cats in Vietnam - An emerging zoonotic issue? Infect. Genet. Evol. 2016;37:94-98.; Lee RM, Moore LB, Bottazzi ME, Hotez PJ. Toxocariasis in North America: a systematic review. PLoS Negl. Trop. Dis. 2014;8:e3116.; Li K, Lan Y, Luo H, Zhang H, Liu D, Zhang L, Li J.Prevalence, associated risk factors, and phylogenetic analysis of Toxocara vitulorum infection in yaks on the Qinghai Tibetan plateau, China. Korean J Parasitol. 2016;54:645-652.; Liu J, Jiang M, Ma Z, Dietze KK, Zelinskyy G, Yang D, Dittmer U, Schlaak JF, Roggendorf M, Lu M.TLR1/2 ligand stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8 + T cell immunity in vitro. J. Immunol. 2013;191:6178-6190.; Loukas AC, Hintz M, Linder D, Mullin NP, Parkinson J, Tetteh KK, Maizels RM.A family of secreted mucins from the parasitic nematode Toxocara canis bears diverse mucin domains but shares similar flanking six-cysteine repeat motifs. J. Biol. Chem. 2000a; 275:39600-7.; Loukas AC, Doedens A, Hintz M, Maizels RM.Identification of a new C-type lectin, TES-70, secreted by infective larvae of Toxocara canis, which binds to host ligands. Parasitology 2000a. 2000b;121:545-554.; Lucio-Forster A, Mizhquiri JF, Mohammed HO, Kornreich BG, Bowman DD.Comparison of the prevalence of Toxocara egg shedding by pet cats and dogs in the U.S.A., 2011–2014. Vet. Parasitol. Reg. Stud. Reports. 2016;5:1-13.; Macpherson CN. The epidemiology and public health importance of toxocariasis: a zoonosis of global importance. Int. J. Parasitol. 2013;43:999-1008.; Ma F, Zhang J, Zhang J, Zhang C. The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice. Cell Mol. Immunol. 2010;7:381-388.; Ma G, Holland CV, Wang T, Hofmann A, Fan C, Maizels RM, Hotez PJ, Gasser RB. Human toxocariasis. Lancet Infect. Dis. 2018a;18:e14-e24.; Ma G, Wang T, Korhonen PK, Nie S, Reid GE, Stroehlein AJ, Koehler AV, Chang BCH, Hofmann A, Young ND, Gasser RB. Comparative bioinformatic analysis suggests that specific dauer-like signalling pathway components regulate Toxocara canis development and migration in the mammalian host. Parasite. Vector. 2019;12:32.; Ma GX, Zhou RQ, Hu L, Luo YL, Luo YF, Zhu HH. Molecular characterization and transcriptional analysis of the female-enriched chondroitin proteoglycan 2 of Toxocara canis. J. Helminthol. 2018b;92:154-160.; Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J. Parasitol. 2001;39:1-11.; Malheiro A, Aníbal FF, Martins-Filho OA, Teixeira-Carvalho A, Perini A, Martins MA, Medeiros AI, Turato WM, Acencio MPM, Brandão IT, Nomizo A, Silva CL, Facciolia LH. pcDNA-IL-12 vaccination blocks eosinophilic inflammation but not airway hyperresponsiveness following murine Toxocara canis infection. Vaccine. 2008;26:305-315.; Maizels RM, Tetteh KK, Loukas A. Toxocara canis: genes expressed by the arrested infective larval stage of a parasitic nematode. Int. J. Parasitol. 2000;30:495-450.; Maizels RM. Toxocara canis: Molecular basis of immune recognition and evasion. Vet. Parasitol. 2013;193:365-374.; Maizels RM, Loukas A. 2001. The surface and secreted antigens of Toxocara canis: genes, protein structure and function. In: Kennedy MW, Harnett W. (Eds.), Parasitic Nematodes: Molecular Biology, Biochemistry and Immunology. Wallingford, UK, pp. 229–247.; Maizels RM. 2006. Molecular biology and immunology of Toxocara canis. In: Holland CV, Smith HV. (1st ed) Toxocara The Enigmatic Parasite. CABI Publishing. United Kingdom, Wallingford, pp. 3-17.; Maizels RM, Mcsorley HJ. Regulation of the host immune system by helminth parasites. J. Allergy Clin. Immunol. 2016;138:666-675.; Mardis ER. The impact of next-generation sequencing technologyon genetics. Trends Genet. 2008;24:133-141.; Marmor M, Glickman L, Shofer F, Faich LA, Rosenberg CARL, Cornblatt BAR, Friedman S. Toxocara canis infection of children: epidemiologic and neuropsychologic findings. Am. J. Public Health. 1987;77:554-559.; Martín UO, Cordani FM, Demonte MA, Pepino S, García LD. Hacia un control inmunológico de la toxocariasis: inmunoprotección en canes con antígenos de Toxocara canis. Rev. Vet. 2016;27:28-31.; Martínez-Orellana P, Quirola-Amores P, Montserrat-Sangrà S, Ordeix L, Llull J, Álvarez-Fernández A, Solano-Gallego L. The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex vivo whole blood from sick and resistant dogs. Parasit. Vectors. 2017;10:123.; Marty-Roix R, Vladimer GI, Pouliot K, Weng D, Buglione-Corbett R, West K, MacMicking JD, Chee JD, Wang S, Lu S, Lien E. Identification of QS-21 as an Inflammasome-activating molecular component of saponin adjuvants. J. Biol. Chem. 2016;291:1123-1136.; Marques JP, Guimarães C, Boas AV, Carnaúba PU, de Moraes J.Contamination of public parks and squares from Guarulhos (São Paulo State, Brazil) by Toxocara spp. and Ancylostoma spp. Rev. Inst. Med. trop. S. Paulo. 2012;54:267-271.; Meghji M, Maizels RM. Biochemical properties of larval excretory-secretory glycoproteins of the parasitic nematode Toxocara canis. Mol. Biochem. Parasitol. 1986;18:155-170.; Mendonça LR, Veiga RV, Dattoli VCC, Figueiredo CA, Fiaccone R, Santos J, Cruz AA, Rodrigues LC, Cooper PJ, Pontes-de-Carvalho LC, Barreto ML, Alcantara-Neves NM.Toxocara seropositivity, atopy and wheezing in children living in poor neighbourhoods in urban Latin American. PLoS Negl Trop Dis. 2012;6:e1886.; Merigueti YF, Santarém VA, Ramires LM, da Silveira BA, da Costa BLV, Nuci AL, de Paula ETM. Protective and risk factors associated with the presence of Toxocara spp. eggs in dog hair. Vet. Parasitol. 2017;244:39-43.; Moawad MA, Amin MM, Hafez EN. Role of Ionizing radiation on Controlling Kidney Changes in Experimental Infection with Toxocara canis. Assiut Vet. Med. J. 2015;61:87-94.; Mojžišová J, Süli J, Goldová M, Bajová V, Švrček Š.The effect of endoparasitism on the immune response to antirabies vaccination in puppies. Acta Parasit. 2007;52:176.; Mora M, Veggi D, Santini L, Pizza M, Rappuoli R. Reverse vaccinology. Drug Discov. Today. 2003;8:459-464.; Moreira GMS, de Lima Telmo P, Mendonça M, Moreira ÂN, McBride AJA, Scaini CJ, Conceição FR. Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol. 2014;30:456-464.; Moorhouse DE. Toxocariasis. A possible cause of the Palm Island mystery disease. Med J Aust. 1982;1:172-173.; Munn EA. Rational design of nematode vaccines: Hidden antigens.Int. J. Parasitol. 1997;27:359-366.; Newton SE, Munn EA. The development of vaccines against gastrointestinal nematode parasites, particularly Haemonchus contortus. Parasitol. Today. 1999;15:116-122.; Nicholas WL, Stewart AC, Mitchell GF. Antibody responses to Toxocara canis using sera from parasite-infected mice and protection from toxocariasis by immunisation with es antigens. Anst. H. Eip. Biol. Med. Sci. 1984;62:619-626.; Nikolić A, Nikolić A, Dimitrijević S, Katić-Radivojević S, Klun I, Bobić B, Djurković-Djaković O. High prevalence of intestinal zoonotic parasites in dogs from Belgrade, Serbia. Acta Vet. Hung. 2008;56:335-340.; Nisbet AJ, McNeilly TN, Wildblood LA, Morrison AA, Bartley DJ, Bartley Y, Longhi C, McKendrick IJ, Palarea-Albaladejo J, Matthews JB. Successful immunization against a parasitic nematode by vaccination with recombinant proteins. Vaccine, 2013;31:4017-4023.; Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, McKenzie ANJ.Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464:1367-1370.; Newman MJ, Wu JY, Gardner BH, Munroe KJ, Leombruno D, Recchia J, Kensil CR, Coughlin RT. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J. Immunol. 1992;148:2357-2362.; Öge H, Öge S, Özbakış G, Gürcan S. Comparison of Toxocara eggs in hair and faecal samples from owned dogs and cats collected in Ankara, Turkey. Vet. Parasitol. 2014;206:227-231.; O’Hagan DT, Valiante NM. Recent advances in the discovery and delivery of vaccine adjuvants. Nat. Rev. Drug Discov. 2003;2:727-735.; Ooi HK, Lin CL, Wang JS. Effect of ozone treatment on Toxocara canis eggs. J. Vet. Med. Sci. 1998;60:169-173.; Overgaauw PAM. Aspects of Toxocara Epidemiology: Toxocarosis in Dogs and Cats. Crit. Rev. Microbiol. 1997;2:233-251.; Petithory JC, Beddock A. Rôle de Toxocara cati dans le syndrome de larva migrans viscéral. Bull. Soc. Fr. Parasitol. 1997;15:199-211.; Petrovsky N, Aguilar JC. Vaccine adjuvants: Current state and future trends. Immunol. Cell Biol. 2004;82:488-489.; Poulsen CS, Skov S, Yoshida A, Skallerup P, Maruyama H, Thamsborg SM, Nejsum P. Differential serodiagnostics of Toxocara canis and Toxocara cati - is it possible? Parasite Immunol. 2015;37:204-207.; Pratti JES, Ramos TD, Pereira JC, da Fonseca-Martins AM, Maciel-Oliveira D, Oliveira-Silva G, de Mello MF, Chaves SP, Gomes DCO, Diaz BL, Rossi-Bergmann B, Guedes HL. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice. Parasit. Vectors. 2016;9:534.; Prociv P. Larval migration in oral and parenteral Toxocara pteropodis infections and a comparison with T. canis dispersal in the flying fox, Pteropus poliocephalus. Int. J. Parasitol. 1989;19:891-896.; Rappuoli R. Reverse vaccinology. Curr. Opin. Microbiol. 2000;3:445-450.; Reed SG, Hsu FC, Carter D, Orr MT. The science of vaccine adjuvants: advances in TLR4 ligand adjuvants. Curr. Opin. Immunol. 2016;41:85-90.; Regis SCS, Mendonça LR, dos Santos Silva N, Dattoli VCC, Alcântara-Neves NM, Barrouin-Melo SM. Seroprevalence and risk factors for canine toxocariasis by detection of specific IgG as a marker of infection in dogs from Salvador, Brazil. Acta Trop. 2011;120:46-51.; Roddie G, Stafford P, Holland C, Wolfe A. Contamination of dog hair with eggs of Toxocara canis. Vet Parasitol. 2008;152:85-93.; Santos LN, Pacheco LGC, Pinheiro CS, Alcantara-Neves NM. Recombinant proteins of helminths with immunoregulatory properties and their possible therapeutic use. Acta Trop. 2017;166:202-211.; Schabussova I, Amer H, van Die I, Kosma P, Maizels RM. O-methylated glycans from Toxocara are specific targets for antibody binding in human and animal infections. Int. J. Parasitol. 2007;37:97-109.; Schantz PM, Meyer D, Glickman LT. Clinical, serologic, and epidemiologic characteristics of ocular toxocariasis. Am. J. Trop. Med. Hyg. 1979;28:24-28.; Scheibeck R, Pallauf M, Stellwag C, Seeberger B. Elderly people in many respects benefit from interaction with dogs. Eur. J. Med. Res. 2011;16:557-563.; Schoenardie ER, Scaini CJ, Brod CS, Pepe MS, Villela MM, McBride AJ, Borsuk S, Berne ME. Seroprevalence of Toxocara infection in children from southern Brazil. J. Parasitol. 2013;99:537-539.; Sette A, Rappuoli R. Reverse Vaccinology: Developing Vaccines in the Era of Genomics. Immunity. 2010;33:530-541.; Silva MB, Amor AL, Santos LN, Galvão AA, Vera AVO, Silva ES, Barbosa CG, Cooper PJ, Figueiredo CA, Ribeiro R, Alcântara-Neves NM. Risk factors for Toxocara spp. seroprevalence and its association with atopy and asthma phenotypes in school-age children in a small townand semi-rural areas of Northeast Brazil. Acta Trop. 2017;174: 158-164.; Singh M, O’Hagan D.Recent advances in veterinary vaccine adjuvants. Int. J. Parasitol. 2003;33:469-478.; Shiny C, Krushna NS, Babu S, Elango S, Manokaran G, Narayanan RB. Recombinant Wolbachia heat shock protein 60 (HSP60) mediated immuneresponses in patients with lymphatic filariasis. Microbes Infect. 2011;13:1221-1231.; Smith KA, Harcus Y, Garbi N, Hämmerling GJ, MacDonald AS, Maizels RM.Type 2 innate immunity in helminth infection is induced redundantly and acts autonomously following CD11c+ cell depletion. Infect. Immun. 2012;80:3481-3489.; Smith WD, Zarlenga DS. Developments and hurdles in generating vaccines for controlling helminth parasites of grazing ruminants. Vet. Parasitol. 2006;139:347-359.; Soltys J, Borosková Z, Dubinský P, Tomasovicová O, Auer H, Spöck H. Effect of glucan immunomodulator on the immune response and larval burdens in mice with experimental toxocarosis. Appl Parasitol. 1996;37:161-167.; Soriano SV, Pierangeli NB, Roccia I, Bergagna HFJ, Lazzarini LE, Saiz MS, Kossman A, Contreras PA, Arias C, Basualdo JA. A wide diversity of zoonotic intestinal parasites infects urban and rural dogs in Neuquén, Patagonia, Argentina. Vet. Parasitol. 2010;167:81-85.; Sowemimo OA. Prevalence and intensity of Toxocara canis (Werner, 1782) in dogs and its potential public health significance in Ile-Ife, Nigeria. J. Helminthol. 2007;81:433-438.; Sowemimo OA, Lee YL, Asaolu SO, Chuang TW, Akinwale OP, Badejoko BO, Gyange VP, Nwafore T, Henry E, Fan CK. Seroepidemiological study and associated risk factors of Toxocara canis infection among preschool children in Osun State, Nigeria. Acta Trop. 2017;173:85-89.; Sperotto RL, Kremer FS, Berne MEA, de Avila LFC, da Silva Pinto L, Monteiro KM, Caumo KS, Ferreira HB, Berne N, Borsuk S.Proteomic analysis of Toxocara canis excretory and secretory (TES) proteins. Mol Biochem. Parasitol. 2017;211:39-47.; Steinhagen F, Kinjo T, Bode C, Klinman DM. TLR-based immune adjuvants. Vaccine. 2011;29:3341-3355.; Strube C, Heuer L, Janecek E. Toxocara spp. infections in paratenic hosts. Vet. Parasitol. 2013;193:375-389.; Sugane K, Kusama Y, Takamoto M, Tominaga A, Takatsu K. Eosinophilia, IL-5 level and recovery of larvae in IL-5 transgenic mice infected with Toxocara canis. J. Helminthol. 1996;70:153-158.; Symeonidou I, Gelasakis AΙ, Arsenopoulos KV, Schaper R, Papadopoulos E.Regression models to assess the risk factors of canine gastrointestinal parasitism. Vet. Parasitol. 2017;248:54-61.; Taylor MR, Keane CT, O’connor P, Anthony Girdwood RW, Smith H.Clinical features of covert toxocariasis. Scand. J. Infect. Dis. 1988;1:692-695.; Taylor MH, O’connor P, Keane CT, Mulvihill E, Holland C. The expanded spectrum of toxocaral disease. Lancet. 1988;1:692-695.; Torgerson P, Budke C. 2006. Economic Impact of Toxocara spp. In: Holland, C.V., Smith HV. (1st ed) Toxocara The Enigmatic Parasite. CABI Publishing. United Kingdom, Wallingford, pp. 281-293.; Ulanova M. The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect. Immun. 2001;69:1151-1159.; Van Kooyk Y, Geijtenbeek TBH. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 2003;3:697-709.; Wolfe A, Wright IP. Human toxocariasis and direct contact with dogs. Vet Rec. 2003;152:419-422.; WHO (World Health Organization), 2017. Zoonoses and the Human-Animal-Ecosystems Interface. World Health Organization. http://www.who.int/zoonoses/en/ (search October 20, 2017).; Won KY.National seroprevalence and risk factors for Zoonotic Toxocara spp. infection. Am. J. Trop. Med. Hyg. 2008;79:552-527.; Zahabiu F, Sadjjadi SM, Yunus MH, Rahumatullah A, Moghaddam MH, Saidin S, Noordin R. Production of Toxocara cati TES-120 Recombinant Antigen and Comparison with its T. canis Homolog for Serodiagnosis of Toxocariasis. Am. J. Trop. Med. Hyg. 2015;93:319-325.; Zhou RQ, Ma GX, Korhonen PK, Luo YL, Zhu HH, Luo YF, Gasser RB, Xia QY.Comparative transcriptomic analyses of male and female adult Toxocara canis. Gene. 2017;600:85-89.; Zhu XQ, Gasser RB, Jacobs DE, Hung GC, Chilton NB. Relationships among some ascaridoid nematodes based on ribosomal DNA sequence data. Parasitol. Res. 2000;86:738-744.; Zhu XQ, Jacobs DE, Chilton NB, Sani RA, Cheng NA, Gasser RB. Molecular characterization of a Toxocara variant from cats in Kuala Lumpur Malaysia. Parasitology. 1998;117:155-164.; Zhu XQ, Korhonen PK, Cai H, Young ND, Nejsum P, von Samson-Himmelstjerna G, Boag PR, Tan P, Li Q, Min J, Yang Y, Wang X, Fang X, Hall RS, Hofmann A, Sternberg PW, Jex AR, Gasser RB. Genetic blueprint of the zoonotic pathogen Toxocara canis. Nat. Commun. 2015;6:6145.; https://orinoquia.unillanos.edu.co/index.php/orinoquia/article/download/631/1169; 95; 79; 24; Orinoquia; https://repositorio.unillanos.edu.co/handle/001/3991; https://doi.org/10.22579/20112629.631

  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal

    المساهمون: Wellcome Trust, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais

    المصدر: BMC Bioinformatics ; volume 19, issue 1 ; ISSN 1471-2105

  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal

    وصف الملف: text

    Relation: https://researchonline.lshtm.ac.uk/id/eprint/4645626/1/Global%20Issues%20in%20Allergy_GREEN%20AAM.pdf; Cruz, Alvaro A; Cooper, Philip J; Figueiredo, Camila A; Alcantara-Neves, Neuza M; Rodrigues, Laura C ; Barreto, Mauricio L; (2017) Global issues in allergy and immunology: Parasitic infections and allergy. The Journal of allergy and clinical immunology, 140 (5). pp. 1217-1228. ISSN 0091-6749 DOI: https://doi.org/10.1016/j.jaci.2017.09.005

  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
  19. 19
    Academic Journal

    المساهمون: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado da Bahia, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

    المصدر: Protein Expression and Purification ; volume 199, page 106150 ; ISSN 1046-5928

  20. 20
    Academic Journal